Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LPKR.JK
HoldBargain BinPT Lippo Karawaci Tbk · Healthcare · Indonesia · $249M · Avg Vol: $726K/d
40
StockRankGet insider-trade alerts
Q
42
V
63
M
28
P/E (TTM)
6.2x
ROE
2.6%
D/E
0.3x
Dividend %
—
COMPANY DESCRIPTION
PT Lippo Karawaci Tbk engages in real estate development, healthcare and lifestyle businesses in Indonesia.
FINANCIAL SUMMARY (IDR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.7T | 16.7T | 11.3T | 8.8T | -15.5% | 8.3T | 8.2T | 7.5T | -7.7% |
| EPS (IDR) | -38.00 | 0.71 | 264.49 | 6.62 | 205.4% | 10.11 | 10.10 | — | 52.6% |
| Shares | 70.9B | 70.9B | 70.9B | 70.9B | -0.0% | 70.9B | — | — | — |
| Debt | 21.2T | 20.3T | 10.2T | 9.6T | -23.1% | 9.9T | — | — | — |
| Equity | 15.3T | 15.3T | 29.9T | 30.1T | 25.3% | — | — | — | — |
| Op CF | -235.1B | 2.1T | 1.7T | -1.6T | -16.3% | -1.0T | — | — | — |
| Inv CF | -1.5T | -978.8B | 9.4T | -856.2B | — | — | — | — | — |
| Fin CF | -532.1B | -1.1T | -8.4T | -885.9B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+1.6%
SMA 50SMA 200
Close
$0.0035
RSI (14)
41.7
52W High
$0.0082
From 52W High
0.4%
SCORE BREAKDOWN
Quality
42
ROIC
3.5%52.2
ROE
2.6%49.7
GP/Assets
6.1%19.8
Op. Margin
15.5%75.8
FCF/Assets
-1.0%42.6
Piotroski
316.1
Int. Cover
1.8x41.8
D/E Ratio
0.32x39.9
Current Ratio
3.79x63.8
Value
63
P/E (TTM)
6.2x96.0
EV/EBITDA
14.6x49.4
P/FCF
—N/A
P/B
0.1x99.9
P/S
0.5x92.3
Div Yield
—N/A
Momentum
28
52W High %
43%16.4
RS 6M
-14%47.3
SMA 50/200
0.78x14.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$249M
P/E (Forward)
23.5x
Gross Margin
35.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LPKR.JK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LPKR.JK | PT Lippo Karawaci Tbk(you) | $249M | 40 | Hold |
| SAME.JK | PT Sarana Meditama Metropolitan Tbk | $308M | 46 | Hold |
| HEAL.JK | PT Medikaloka Hermina Tbk | $589M | 35 | Sell |
| SILO.JK | PT Siloam International Hospitals Tbk | $1.6B | 78 | Buy |
| MIKA.JK | PT Mitra Keluarga Karyasehat Tbk | $1.5B | 84 | Strong Buy |
| SRAJ.JK | PT Sejahteraraya Anugrahjaya Tbk | $9.2B | 13 | Strong Sell |
| KAEF.JK | PT Kimia Farma Tbk | $150M | 35 | Hold |
| PYFA.JK | PT Pyridam Farma Tbk | $168M | 9 | Strong Sell |
| SOHO.JK | PT Soho Global Health Tbk | $1.2B | 57 | Hold |
| MARK.JK | PT Mark Dynamics Indonesia Tbk | $233M | 100 | Strong Buy |
Peer medians: ROE 9.2% · P/E 20.2x · Gross margin 37.3%